Non-Applicability of Regulation 32(1) of SEBI.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Transgene Biotek Ltd has submitted a filing to BSE stating that Regulation 32(1) of the SEBI Listing Obligations and Disclosure Requirements (LODR) is not applicable to the company. This regulation requires listed companies to report any deviations or variations in the use of funds raised through public issues, rights issues, or preferential issues. By declaring it non-applicable, the company is likely indicating that it has not raised funds through such routes, or that there are no proceeds whose usage needs to be tracked and reported. Note: The full document content could not be retrieved from the source link (BSE page error), so additional details are not available.
This is generally a routine compliance disclosure with no material impact on shareholders or the stock price, as it simply confirms a regulation does not apply to the company's current situation.